What are the guidelines for treating neonatal sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neonatal Sepsis Treatment Guidelines

First-Line Empiric Therapy for Early-Onset Sepsis

The WHO recommends ampicillin plus gentamicin as the standard first-line empiric treatment for early-onset neonatal sepsis, providing coverage against Group B Streptococcus, E. coli, and Listeria monocytogenes. 1, 2, 3

Dosing Considerations

  • Ampicillin dosing for neonates ≤28 days varies by gestational and postnatal age 4:

    • Gestational age ≤34 weeks, postnatal age ≤7 days: 100 mg/kg/day divided every 12 hours 4
    • Gestational age ≤34 weeks, postnatal age 8-28 days: 150 mg/kg/day divided every 12 hours 4
    • Gestational age >34 weeks, postnatal age ≤28 days: 150 mg/kg/day divided every 8 hours 4
  • Gentamicin is indicated for serious gram-negative infections including neonatal sepsis, with dosing adjusted for gestational and postnatal age 5

  • In neonates with suspected bacterial sepsis, a penicillin-type drug is usually indicated as concomitant therapy with gentamicin 5

Critical Timing Requirements

Antibiotics must be initiated within 1 hour for septic shock and within 3 hours for sepsis without shock. 1, 2

  • Blood cultures should be obtained before antibiotic administration, but never delay treatment waiting for results 1, 2

  • Empiric therapy should be started immediately after cultures are obtained without awaiting results 6

Late-Onset and Hospital-Acquired Sepsis

For hospital-acquired neonatal infections, the WHO recommends amikacin plus cloxacillin as first-line therapy, providing coverage against resistant staphylococci and gram-negative bacteria. 1, 3

  • Vancomycin plus ceftazidime should replace the above when methicillin-resistant staphylococci or resistant gram-negative bacteria are suspected 1

  • Hospital-acquired pathogens include coagulase-negative staphylococci, enterococci, and Pseudomonas aeruginosa 6

When to Escalate or Modify Therapy

Add cefotaxime when there is evidence or strong suspicion of gram-negative sepsis. 1, 2, 3

  • Escalate therapy immediately if no clinical improvement occurs after 48-72 hours of initial empiric therapy 1, 2

  • Adjust therapy based on blood culture results and antimicrobial susceptibility testing 2, 6

  • For bacterial meningitis, increase ampicillin dosing to 150-200 mg/kg/day in divided doses every 3-4 hours 4

Regional Resistance Patterns: A Critical Caveat

In low- and middle-income countries, 97% of gram-negative isolates show ampicillin resistance, and only 28.5% of gram-negative isolates remain susceptible to ampicillin-gentamicin combinations. 7

  • Less than one-quarter of neonates globally receive WHO-recommended first- or second-line antibiotics, with meropenem being the most commonly prescribed empiric antibiotic in LMICs (15.9% of regimens) 7, 1

  • Resistance to gentamicin and ceftriaxone is similarly concerning across all key groups of gram-negative bacteria in LMICs 7

  • Local antibiotic resistance patterns must dictate empiric therapy choices 1, 2

Duration of Therapy and Discontinuation

Discontinue antibiotics after 48 hours if blood cultures are negative and the infant remains asymptomatic with low probability of sepsis. 1, 8, 9

  • Time to positivity (TTP) of blood cultures with pathogenic organisms is <48 hours in 100% of cases, with mean TTP of 17.7 hours versus 80.5 hours for contaminants 8

  • For proven sepsis with minimal or absent focal infection, continue therapy for 10-14 days 6, 10

  • Treatment should continue for a minimum of 48-72 hours beyond clinical improvement or bacterial eradication 4

  • For Group A beta-hemolytic streptococcal infections, treat for minimum 10 days to prevent acute rheumatic fever or glomerulonephritis 4

Common Pitfalls to Avoid

  • Prolonged empiric treatment (≥5 days) with broad-spectrum antibiotics in preterm infants increases risks of late-onset sepsis, necrotizing enterocolitis, and mortality 9

  • Failing to adjust therapy based on culture results and clinical response leads to treatment failure 2, 3

  • Ignoring local antimicrobial resistance patterns when selecting empiric therapy is a critical error 1, 2

  • More rapid intravenous administration of ampicillin than recommended (faster than 10-15 minutes for 1-2g doses) may result in convulsive seizures 4

Special Considerations for Meningitis

  • When clinical signs suggest sepsis, perform lumbar puncture if feasible, as blood cultures can be sterile in up to 15% of newborns with meningitis 7

  • If lumbar puncture is deferred and empiric therapy continues beyond 48 hours due to clinical instability, obtain CSF for analysis 7

  • Bacterial meningitis requires higher ampicillin dosing (150-200 mg/kg/day) and may require initiation with intravenous therapy for at least 3 days 4

References

Guideline

Neonatal Sepsis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento de Sepsis Neonatal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Therapy for Neonatal Sepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic use in neonatal sepsis.

The Turkish journal of pediatrics, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.